Literature DB >> 21103388

Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

Brent K Rubio1, Stephen M Parrish, Wesley Yoshida, Peter J Schupp, Tom Schils, Philip G Williams.   

Abstract

Bouillomides A (1) and B (2) are two depsipeptide analogues of dolastatin 13. Isolated from a Guamanian sample of Lyngbya bouillonii, the planar structures were elucidated on the basis of HR-ESI-MS and NMR data, while the absolute configurations were determined by employing functional group conversions, modified Marfey's analysis, and detailed analyses of ROESY correlations. Compounds 1 and 2 selectively inhibited serine proteases elastase (IC(50) = 1.9 μM for both) and chymotrypsin (IC(50) = 0.17 and 9.3 μM, respectively) while showing no inhibition of trypsin (IC(50) > 100 μM).

Entities:  

Year:  2010        PMID: 21103388      PMCID: PMC2987581          DOI: 10.1016/j.tetlet.2010.10.062

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

1.  Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.

Authors:  H Luesch; W Y Yoshida; R E Moore; V J Paul
Journal:  J Nat Prod       Date:  1999-12       Impact factor: 4.050

2.  Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Cliff Ross; James R Rocca; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2007-01       Impact factor: 4.050

3.  Recovery of tryptophan in peptides and proteins by high-temperature and short-term acid hydrolysis in the presence of phenol.

Authors:  K Muramoto; H Kamiya
Journal:  Anal Biochem       Date:  1990-09       Impact factor: 3.365

4.  Conservation and variability in the structures of serine proteinases of the chymotrypsin family.

Authors:  A M Lesk; W D Fordham
Journal:  J Mol Biol       Date:  1996-05-10       Impact factor: 5.469

5.  Micropeptins from an Israeli fishpond water bloom of the cyanobacterium Microcystis sp.

Authors:  Ella Zafrir; Shmuel Carmeli
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

6.  Cyanopeptolin 954, a chlorine-containing chymotrypsin inhibitor of Microcystis aeruginosa NIVA Cya 43.

Authors:  Eric von Elert; Lukas Oberer; Petra Merkel; Thomas Huhn; Judith F Blom
Journal:  J Nat Prod       Date:  2005-09       Impact factor: 4.050

Review 7.  Structural basis of substrate specificity in the serine proteases.

Authors:  J J Perona; C S Craik
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

8.  Isolation and structure determination of lyngbyastatin 3, a lyngbyastatin 1 homologue from the marine cyanobacterium Lyngbya majuscula. Determination of the configuration of the 4-amino-2,2-dimethyl-3-oxopentanoic acid unit in majusculamide C, dolastatin 12, lyngbyastatin 1, and lyngbyastatin 3 from cyanobacteria.

Authors:  Philip G Williams; Richard E Moore; Valerie J Paul
Journal:  J Nat Prod       Date:  2003-10       Impact factor: 4.050

9.  Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.

Authors:  G G Harrigan; W Y Yoshida; R E Moore; D G Nagle; P U Park; J Biggs; V J Paul; S L Mooberry; T H Corbett; F A Valeriote
Journal:  J Nat Prod       Date:  1998-10       Impact factor: 4.050

10.  Recombination and selectional forces in cyanopeptolin NRPS operons from highly similar, but geographically remote Planktothrix strains.

Authors:  Trine B Rounge; Thomas Rohrlack; Tom Kristensen; Kjetill S Jakobsen
Journal:  BMC Microbiol       Date:  2008-08-26       Impact factor: 3.605

View more
  11 in total

1.  Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

Authors:  Lena Keller; Kirley Marques Canuto; Chenxi Liu; Brian M Suzuki; Jehad Almaliti; Asfandyar Sikandar; C Benjamin Naman; Evgenia Glukhov; Danmeng Luo; Brendan M Duggan; Hendrik Luesch; Jesko Koehnke; Anthony J O'Donoghue; William H Gerwick
Journal:  ACS Chem Biol       Date:  2020-01-28       Impact factor: 5.100

Review 2.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

Review 3.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

4.  Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds.

Authors:  Margarida Costa; Mónica Garcia; João Costa-Rodrigues; Maria Sofia Costa; Maria João Ribeiro; Maria Helena Fernandes; Piedade Barros; Aldo Barreiro; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2013-12-31       Impact factor: 5.118

Review 5.  α,β-Dehydroamino acids in naturally occurring peptides.

Authors:  Dawid Siodłak
Journal:  Amino Acids       Date:  2014-10-17       Impact factor: 3.520

Review 6.  New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Authors:  Yue Mi; Jinrong Zhang; Shan He; Xiaojun Yan
Journal:  Mar Drugs       Date:  2017-05-05       Impact factor: 5.118

7.  Applying a Chemogeographic Strategy for Natural Product Discovery from the Marine Cyanobacterium Moorena bouillonii.

Authors:  Christopher A Leber; C Benjamin Naman; Lena Keller; Jehad Almaliti; Eduardo J E Caro-Diaz; Evgenia Glukhov; Valsamma Joseph; T P Sajeevan; Andres Joshua Reyes; Jason S Biggs; Te Li; Ye Yuan; Shan He; Xiaojun Yan; William H Gerwick
Journal:  Mar Drugs       Date:  2020-10-14       Impact factor: 5.118

8.  Bursatella leachii Purple Ink Secretion Concentrate Exerts Cytotoxic Properties against Human Hepatocarcinoma Cell Line (HepG2): In Vitro and In Silico Studies.

Authors:  Zeyad I Alehaideb; Anuradha Venkatraman; Mahadev Kokane; Syed Ali Mohamed; Saranya Rameshbabu; Rasha S Suliman; Sahar S Alghamdi; Hamad Al-Eidi; Bandar Alghanem; Maha-Hamadien Abdulla; Sabine Matou-Nasri
Journal:  Molecules       Date:  2022-01-26       Impact factor: 4.411

Review 9.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

Review 10.  Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.

Authors:  Lik Tong Tan; Ma Yadanar Phyo
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.